Who can receive the first dose of Verocell vaccine being administered from today?

KATHMANDU, September 20: The government is administering Verocell vaccine against COVID-19 across the country from today. The vaccination drive will be conducted for the next 11 days starting from Monday, according to the Ministry of Health and Population (MoHP). The vaccine will be provided to those eligible age groups who have received any shots of COVID-19 vaccine in various districts of the country, an official at the health ministry said.  Who can receive the vaccine? 1) People in Taplejung, Sankhuwasabha, Solukhumbu, Rasuwa, Jumla, Mugu, Humla, Dolpa, Bajura and Darchula who are more than 18 years old. 2) People living in Kavre and Chitwan who are older than 35 years old. Students of eligible age groups who had missed their jabs earlier. 3) People living in Kathmandu, Lalitpur, Bhaktapur, Makwanpur, Ramechap, Sarlahi and Acham who are older than 40 years and students of eligible age groups who had missed their jabs earlier. 4) In the remaining 58 districts, the vaccine will be administered to people who are older than 35 years old and students of eligible age group except for Manang, Mustang and East Rukum.  5) Besides the vaccine, the first dose of the vaccine will also be administered to frontline workers, teachers, those working in tourism sectors and hotels who have not received any shot of COVID-19 vaccine yet. Meanwhile, the governmnet has also begun administering the second dose of Verocell vaccine in Kathmandu district. (With inputs from Gorkhapatra)

सम्बन्धित सामग्री

China approves inhaled Covid vaccine

SEPT 6: Made by CanSino, it has similar ingredients to its injected vaccine, using a harmless adenovirus as a carrier for the genetic code that teaches the body how to fight Covid. Inhaled as a fine mist, Convidecia Air can provide good protection after just one breath, the company says. Other researchers, including teams in the UK and the US, have been investigating nasal spray vaccines. Scientists say these may give added immunity in the lining of the nose and upper airways, where Covid typically enters the body. The National Medical Products Administration of China granted CanSino approval for its inhaled vaccine to be used as a booster dose. It can top up protection in those who have previously had a jab, trials suggest. Meanwhile, the latest Covid vaccine booster programme has begun in England, Wales and Scotland. Infections are falling around the UK - but health bosses predict a resurgence of Covid and flu this autumn and winter. They are urging those eligible to protect themselves from serious illness by being vaccinated against both.

FDA restricts J&J’s COVID-19 vaccine

US regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots

Things to know about typhoid conjugate vaccine

KATHMANDU, April 6: The government is has announced to administer the Typhoid vaccine to children all across the country. According to the government’s data, as many as 450,000 people have been found infected with typhoid. According to the Department of Health Services, typhoid ranks third among food and water borne diseases in Nepal. Among those infected, most of them are children aged below 15 years old. Similarly, as per a report of the Patan Academy of Health Sciences, around 62,000 people are found infected with typhoid out of 100,000 population. The study was conducted on 100,000 children.  The World Health Organization (WHO) has recommended vaccination against typhoid in Nepal and the government has begun a vaccination drive accordingly. What is the vaccine that is being administered to children against typhoid in Nepal? The government is administering a typhoid vaccine to children aged between 15 months to 15 years for the first time from April 8 to May 1. Nepal is the first country to administer a typhoid vaccine to children in South Asia. Typhoid conjugate vaccine (TCV), to be administered to minors in Nepal, is safe and is recommended by the WHO. “Studies have shown that the typhoid conjugate vaccine is safe, effective, and can provide protection for infants and children under two years of age, unlike the previously available typhoid vaccines,” according to the WHO. “The recommendation for the typhoid conjugate vaccine to be included in routine immunization programs will help pave the way for national authorities to introduce this vaccine in countries where they are needed most.” What is typhoid? Typhoid fever is a life-threatening infection caused by the bacterium Salmonella Typhi. It is usually spread through contaminated food or water. Symptoms include prolonged fever, fatigue, headache, nausea, abdominal pain, and constipation or diarrhea. Some patients may have a rash. Severe cases may lead to serious complications or even death. Typhoid fever can be treated with antibiotics although increasing resistance to different types of antibiotics is making treatment more complicated. Who shouldn’t receive the TCV? - Those experiencing health complacies while receiving vaccines earlier - Those having allergy problems  - Those experiencing symptoms of HIV-AIDS - Those experiencing high fevers

COVID vaccine: CDC expands booster rollout, OKs mixing shots

Millions more Americans can get a COVID-19 booster and choose a different company’s vaccine for that next shot